Drugs / 2:1 EPA/DHA
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT02057406 Comparator | May 2014 → May 2016 | major depressive disorder | Wei Jiang | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | 2:1 EPA/DHA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02057406 ↗ |
| Modality | Other / unclassified | “long-chain omega-3 fatty acid supplementation” PMID 30098961 ↗ Aug 2018 |